Low incidence of reinfection with the hepatitis C virus following treatment in active drug users in Amsterdam
Bart GradyJoost W. VanhommerigJanke SchinkelChristine J. WeeginkSylvia M. BruistenCatherina E.A. LindenburgMaria Prins
Abstract
We report a low incidence of HCV reinfection following treatment in DU participating in a multidisciplinary programme. Active drug use, including injecting, should not preclude access to treatment for HCV.
Metrics
Citation History
Topics
Related Documents
Reinfection with hepatitis C virus following sustained virological response in injection drug users
Jason GrebelyElizabeth KnightTyler NgaiKrista GenowayJesse D. RaffaMichelle StormsLesley GallagherMel KrajdenGregory J. DoreFiona DuncanBrian Conway
Reinfection with hepatitis C virus following sustained virological response in injection drug users
Jason GrebelyElizabeth KnightTyler NgaiKrista GenowayJesse D. RaffaMichelle StormsLesley GallagherMel KrajdenGregory J. DoreFiona DuncanBrian Conway
Reinfection with hepatitis C virus following sustained virological response in injection drug users
Grebely, JasonKnight, ElizabethNgai, TylerGenoway, KristaRaffa, Jesse DanielStorms, MichelleGallagher, LesleyKrajden, MelDore, Gregory J.Duncan, FionaConway, Brian
Hepatitis C virus reinfection in injection drug users
Jason GrebelyBrian ConwayJesse D. RaffaCalvin LaiMel KrajdenMark Tyndall
Hepatitis C virus reinfection in injection drug users
Grebely, JasonConway, BrianRaffa, Jesse DanielLai, CalvinKrajden, MelTyndall, Mark